Safety Study of XT-150 in Participants With ALS
Safety Study of XT-150 in Participants With ALS
Not yet recruiting · NCT06704347 · Registry updated 2026-07-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety Study of XT-150 in Participants With ALS | Nutritional and Metabolic Diseases, TDP-43 proteinopathy, amyotrophic lateral sclerosis, central nervous system disorder, metabolic disease, motor neuron disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, proteostasis deficiencies, spinal cord disorder | Not yet recruiting | Phase 1 | 2026-07-29 | NCT06704347 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Xalud Therapeutics, Inc. | 1 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Barrow Neurological Institute (St. Joseph's) | Phoenix | United States | 1 |
| Henry Ford Health | Detroit | United States | 75 |
| Johns Hopkins University | Baltimore | United States | 60 |
| Massachusetts General Hospital | Boston | United States | 1015 |